Henderson Group »

Lenz Therapeutics shares owned by Henderson Group

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Henderson Group from 13F filings

Historical chart of Henderson Group investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Henderson Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Henderson Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $229k 4.9k 46.64

More positions owned by Henderson Group

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Apple (AAPL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Oracle Corporation (ORCL)
Mastercard Incorporated Cl A (MA)
Eli Lilly & Co. (LLY)
Applovin Corp Com Cl A (APP)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Argenx Se Sponsored Adr (ARGX)
Booking Holdings (BKNG)
Howmet Aerospace (HWM)

View all positions for Henderson Group

Top funds holding Lenz Therapeutics

RA Capital Management
Falcon Edge Capital
Versant Venture Management
UBS Group
BlackRock
Vanguard Group
Franklin Resources
72 Investment Holdings
Tang Capital Management
Adage Capital Partners GP
Intrinsic Edge Capital Management
State Street Corporation
CAM Group Holding A/S
Squarepoint Ops
Standard Life Aberdeen

View all funds holding Lenz Therapeutics